Annual Accounts Receivable
$16.84 M
+$13.54 M+409.80%
December 31, 2023
Summary
- As of February 7, 2025, IPHA annual accounts receivable is $16.84 million, with the most recent change of +$13.54 million (+409.80%) on December 31, 2023.
- During the last 3 years, IPHA annual accounts receivable has risen by +$3.82 million (+29.34%).
- IPHA annual accounts receivable is now -19.79% below its all-time high of $20.99 million, reached on December 31, 2019.
Performance
IPHA Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$421.30 K
-$16.42 M-97.50%
June 30, 2024
Summary
- As of February 7, 2025, IPHA quarterly accounts receivable is $421.30 thousand, with the most recent change of -$16.42 million (-97.50%) on June 30, 2024.
- Over the past year, IPHA quarterly accounts receivable has dropped by -$59.96 million (-99.30%).
- IPHA quarterly accounts receivable is now -99.30% below its all-time high of $60.39 million, reached on June 30, 2023.
Performance
IPHA Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
IPHA Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +409.8% | -99.3% |
| 3 y3 years | +29.3% | -99.3% |
| 5 y5 years | +483.7% | -99.3% |
IPHA Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1657.9% | -99.3% | at low |
| 5 y | 5-year | -19.8% | +1657.9% | -99.3% | at low |
| alltime | all time | -19.8% | -100.0% | -99.3% | -100.0% |
Innate Pharma SA Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $421.30 K(-97.5%) |
| Dec 2023 | $16.84 M(+409.8%) | $16.84 M(-72.1%) |
| Jun 2023 | - | $60.39 M(+1728.2%) |
| Dec 2022 | $3.30 M(+244.8%) | $3.30 M(-63.1%) |
| Jun 2022 | - | $8.95 M(+834.0%) |
| Dec 2021 | $957.90 K(-92.6%) | $957.90 K(-92.2%) |
| Jun 2021 | - | $12.34 M(-5.2%) |
| Dec 2020 | $13.02 M(-38.0%) | $13.02 M(-27.4%) |
| Jun 2020 | - | $17.94 M(-14.6%) |
| Dec 2019 | $20.99 M(+627.7%) | $20.99 M(+234.6%) |
| Jun 2019 | - | $6.27 M(+117.5%) |
| Dec 2018 | $2.88 M(>+9900.0%) | $2.88 M(+1179.3%) |
| Jun 2018 | - | $225.50 K(>+9900.0%) |
| Dec 2017 | $0.00(-100.0%) | $0.00(0.0%) |
| Jun 2017 | - | $0.00(-100.0%) |
| Dec 2016 | $15.04 M | $15.04 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $3300.00(-99.4%) |
| Dec 2015 | $552.10 K(+6.6%) | $552.10 K(+6.3%) |
| Jun 2015 | - | $519.30 K(+0.3%) |
| Dec 2014 | $518.00 K(-81.2%) | $518.00 K(-69.7%) |
| Jun 2014 | - | $1.71 M(-37.9%) |
| Dec 2013 | $2.75 M(-20.9%) | $2.75 M(-4.4%) |
| Jun 2013 | - | $2.88 M(-17.3%) |
| Dec 2012 | $3.48 M(+66.0%) | $3.48 M(+66.0%) |
| Dec 2011 | $2.10 M(-74.1%) | $2.10 M(-64.3%) |
| Jun 2011 | - | $5.87 M(-27.4%) |
| Dec 2010 | $8.09 M(-20.0%) | $8.09 M(-21.0%) |
| Jun 2010 | - | $10.24 M(+1.2%) |
| Dec 2009 | $10.11 M(-51.1%) | $10.11 M |
| Dec 2008 | $20.69 M(+194.5%) | - |
| Dec 2007 | $7.02 M(+19.6%) | - |
| Dec 2006 | $5.87 M(+73.0%) | - |
| Dec 2005 | $3.39 M | - |
FAQ
- What is Innate Pharma SA annual accounts receivable?
- What is the all time high annual accounts receivable for Innate Pharma SA?
- What is Innate Pharma SA annual accounts receivable year-on-year change?
- What is Innate Pharma SA quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Innate Pharma SA?
- What is Innate Pharma SA quarterly accounts receivable year-on-year change?
What is Innate Pharma SA annual accounts receivable?
The current annual accounts receivable of IPHA is $16.84 M
What is the all time high annual accounts receivable for Innate Pharma SA?
Innate Pharma SA all-time high annual accounts receivable is $20.99 M
What is Innate Pharma SA annual accounts receivable year-on-year change?
Over the past year, IPHA annual accounts receivable has changed by +$13.54 M (+409.80%)
What is Innate Pharma SA quarterly accounts receivable?
The current quarterly accounts receivable of IPHA is $421.30 K
What is the all time high quarterly accounts receivable for Innate Pharma SA?
Innate Pharma SA all-time high quarterly accounts receivable is $60.39 M
What is Innate Pharma SA quarterly accounts receivable year-on-year change?
Over the past year, IPHA quarterly accounts receivable has changed by -$59.96 M (-99.30%)